http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2159430-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aee8b494341ba692df941b5e07ff0329 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-48 |
| filingDate | 1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba271684a35bbb5b45d099ebbc7265dc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a7d1924e03c2ef177b7d9410f2207ff1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4f857022bdafebeb885b651f586d47fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7da6f0894e084f836e934b1094cbc49d |
| publicationDate | 2000-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2159430-C1 |
| titleOfInvention | Method for determining individual sensitivity to carbamazepin in the cases of phase-like developing psychoses |
| abstract | FIELD: medicine. SUBSTANCE: method involves determining metabolism index as concentrations ratio of carbamazepin metabolites like 10,11-epoxi- carbamazepin and/or 10,11-diol -carbamazepin to its concentration in biological fluids like blood in 7 days after and not earlier than in 12 h after administering oxcarbazepin. The metabolism index value of 10,11-epoxi-carbamazepin/carbamazepin being not greater than 0.2 and 10,11-diol-carbamazepin/carbamazepin being not greater than 0.3, individual sensitivity to carbamazepin is considered to be the case. EFFECT: accelerated and high accuracy method. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2771430-C1 |
| priorityDate | 1999-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.